| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.25 | 0.06 |